
| MEETING SITE HOME SCHEDULE AUTHOR INDEX SUBJECT INDEX PROGRAM # INDEX ITINERARY SIGNUP |
|
R4 PM Effects and Risk Assessment of Pharmaceutical and Other Emerging Wastewater Contaminants in Aquatic Systems (BRI-1117-726542) Reproductive effects of the pharmaceutical fluoxetine on a native freshwater mussel. Bringolf, R.1, Cope, W.1, Heltsley, R.2, Eads, C.3, Shea, D.1, 1 Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC, USA2 Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, SC, USA3 College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA ABSTRACT- Recently, widespread occurrence of fluoxetine and other pharmaceuticals and personal care products (PPCPs) has been reported in surface waters of the United States and elsewhere; however, impacts of PPCPs on aquatic organisms are largely unknown. Fluoxetine is the active ingredient in the prescription anti-depressant drug ProzacTM, which acts as a selective serotonin reuptake inhibitor (SSRI) to increase serotonin levels at nerve synapses. Serotonin has previously been used to induce parturition/spawning in some bivalves. To determine the potential of fluoxetine to disrupt native freshwater mussel reproduction, we exposed gravid adult female eastern elliptio (Elliptio complanata) mussels to fluoxetine at target concentrations of 0, 0.03, 0.3, 3.0, 30, 300, and 3000 Key words: fluoxetine, reproduction, mussel, pharmaceutical |
|
Internet Services provided by Allen Press, Inc. | 810 E. 10th St. | Lawrence, Kansas 66044 USA e-mail assystant-helpdesk@allenpress.com | Web www.allenpress.com All content is Copyright © 2005 SETAC |